|
|
|
|
| Symbol(s): |
TEVA |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
TEVA has a current Overall Rating of B (Positive). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| TEVA has a current Overall Rating of B (Positive). Appreciation potential (88) is very high; Power Rating (48) is neutral. Relative to the S&P 500 Composite, Teva Pharmaceutical Inds-ADR has moderate Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. TEVA is of high investment quality. TEVA's current technical position is very strong. TEVA's Power Rating is 48. Earnings estimate behavior for TEVA has been slightly negative recently. TEVA's...
| | |
|
|
